Upregulation of JMJD3 inhibits the expression of the transcription factor Oct4 promoting the suppression of tumor growth and diminishing CSC from breast cancer, suggesting JMJD3 as a potential target to overcome resistance mediated by CSC [101]. The gene discussed is KDM6B; the disease is breast carcinoma.